Inside the Telavongo merger — Poor immunity after boosters — Why we don't have a Lyme vaccine

 
Subscribe to Insider View in browser
 
 
 
INSIDER HEALTHCARE
 
 
 
 

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


Livongo's IPO in July 2019.Teladoc acquired Livongo to recreate healthcare. A rushed union, a wave of senior exits, and sky-high expectations are testing the $14 billion bet.

Read the Insider investigation>> 


A woman wearing a mask and blue scrubs gets a shot in a clinic.An immunocompromised man had 4 shots of COVID-19 vaccine but still appears to have poor immunity

Dive in>>


deer tick bitesThe US had a Lyme disease vaccine decades ago — but the CDC, lawsuits, and conspiracy theories derailed it

Read more>> 


More stories we're reading:


-Leah

 
 
 
 
 
INSIDER

Was this email forwarded to you?
 
Download on the app store   Get it on google play
 
You received this email because you signed up to this
Insider newsletter using the
email: aymentanaze.news@blogger.com
 
Email preferences Unsubscribe
TERMS OF SERVICE PRIVACY POLICY
1 Liberty Plaza, 8th Floor. New York, NY 10006
 

Commentaires

Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

Luke from 'Gilmore Girls' is selling out and starting a coffee brand

Sandy Hook Parents Are Criticizing Megyn Kelly For Giving A Platform To ‘Truther’ Alex Jones